medline.ch Gynäkologie Mammae

	Triple Assessment in the Clinical Evaluation of Ductal Breast Disease. Mymensingh Med J Sultana F, Aziz SR, Ara I, Farruk MM, Nusrat F. PMID: 41914117 [PubMed - indexed for MEDLINE]
	Pilot study: prognostic significance of semi-quantitative parameters in baseline fluorineâ€‘18 fluorodeoxyglucose PET/computed tomography in nonmetastatic breast cancer patients. Nucl Med Commun Elsayed ND, Mohamed MT, Abou Gabal MA, Azab RHI, Ahmed MS. PMID: 41913663 [PubMed - as supplied by publisher]
	A Five-Year Retrospective Analysis of Neoadjuvant Therapy in Early-Stage Breast Cancer: Subtype Outcomes and Imaging Concordance. Breast J Javed SR, DeSouza K, Tanzim U, Ottaviani D, Roylance R, Raja F, Walsh T, Koutoukoglou P, Creed C, McFarlane E, Mathur S, Mahapatra A, Papadimitraki E. PMID: 41913651 [PubMed - indexed for MEDLINE]
	ASO Visual Abstract: Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer. Ann Surg Oncol Gallagher K, Feldman S, Barone J, Mammen J, Barone R, Ochoa D, McGinness M, Frazer T, Viscusi R, Lang JE, Lee J, Adkins LL, Johnson S, Henry-Tillman R, Korourian S, Suzanne Klimberg V. PMID: 41913021 [PubMed - as supplied by publisher]
	Economic and Health System Impact of Implementing the SOUND Trial Approach in Early-Stage Breast Cancer. Ann Surg Oncol Shern TP, Holt LR, Lloyd K, Daly AE, Gadd MA, Verdial FC, Kwait RM, Specht MC, Smith BL, Ozmen T. PMID: 41913016 [PubMed - as supplied by publisher]
	A Hybrid Multi-CNN Feature Fusion and LASSO Optimization Approach for High-Performance Breast Cancer Classification. J Imaging Inform Med Beghriche T, Djerioui M, Brik Y, Attallah B, Shayea I. PMID: 41912956 [PubMed - as supplied by publisher]
	Abemaciclib plus fulvestrant in treating hormone-receptor positive, HER2-negative advanced breast cancer-comparing real-world outcomes in England to the MONARCH-2 trial. Br J Cancer Anderson J, Lawton S, Thackray K, Kipps E. PMID: 41912678 [PubMed - as supplied by publisher]
	Natural menopause, menarche and breast cancer risk in BRCA1 and BRCA2 pathogenic variant carriers: a Mendelian randomization analysis. Br J Cancer Mavaddat N, Barnes DR, Michailidou K, Zhao E, Frost D, Leslie G, Dennis J, Wang Q, Bolla MK, EMBRACE, Evans DG, Tischkowitz M, Thompson DJ, Perry JRB, Antoniou AC, Easton DF. PMID: 41912676 [PubMed - as supplied by publisher]
	Novel targeted therapies and immunological strategies for breast cancer treatment. Biochem Pharmacol Mussa A, Hamid M, Talib M, Ehinnou I, Bragoli A, Hajisa K, Mokhtar NF, Mohamud R, Al-Hatamleh MAI, Hassan R. PMID: 41912055 [PubMed - as supplied by publisher]
	Profillin-1 and Transgelin-2: Actin Binding Proteins Expression in Early and Advanced Stages of Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy. Cancer Rep (Hoboken) Shahid MA, Mushtaq S, Khan A, Naseeb U, Haider G, Wasim B. PMID: 41911947 [PubMed - indexed for MEDLINE]
	Clinically Sufficient Vitamin D Levels With Survival and Cardiovascular Outcomes in a Prospective Cohort of 3,995 Individuals Diagnosed With Invasive Breast Cancer. J Natl Compr Canc Netw Yao S, Chua AV Jr, Sheng H, Zimbalist A, Hill JW, Roh JM, D'Addario LL, Laurent CA, Ergas IJ, Cheng TD, Johnson CS, Ambrosone CB, Greenlee H, Kwan ML, Kushi LH. PMID: 41911911 [PubMed - as supplied by publisher]
	CLO26-127: Potential Efficacy of Vitamin D in Improving Pathological Complete Response among Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Systematic Review and Meta-Analysis. J Natl Compr Canc Netw Khalid A, Farrukh MT, Usman T, Tahir M, Ahmed AB, Batool A, Mushtaq S, Mohib K. PMID: 41911905 [PubMed - in process]
	BPI26-031: Comparative Diagnostic and Prognostic Value of FES PET/CT Versus FDG PET/CT in ER-Positive Breast Cancer: An Umbrella Review. J Natl Compr Canc Netw Tara N, Zubair H, Nawaz S, Joy J, Adhikari A, Anand R, Anubhuti F, Jagan SM. PMID: 41911881 [PubMed - in process]
	HSR26-267: Evidence-Based Radiotherapy in Early Breast Cancer: Closing the Hypofractionation Gap. J Natl Compr Canc Netw Okoye C, Emeasoba C, Obialo-Ibeawuchi C, Olanipekun NL, Amaechi U. PMID: 41911864 [PubMed - in process]
	BIO26-046: Validating an LLM for Detecting Enrollment Disparities in Breast Cancer Trials. J Natl Compr Canc Netw Shah Z, Aziz S, Haji M, Aslam F, Buradkar A, Baid U, Gandhi S, Kabraji S. PMID: 41911794 [PubMed - in process]
	HSR26-231: Diagnostic Performance of the Bexaâ„¢ Breast Exam for Detection of Breast Masses: A Prospective Single-Center Study. J Natl Compr Canc Netw Gary M, Hiatt M, Cole J, Battle A, Stewart J, Horton S, Chen S, Kaufman C, Mitchell T. PMID: 41911771 [PubMed - in process]
	CLO26-104: TBCRC 050: A Phase 1b/2 Trial of Niraparib and Trastuzumab in HER2+ Metastatic Breast Cancer (MBC): Safety and Efficacy. J Natl Compr Canc Netw Stringer-Reasor E, Li Y, Zhang J, Rocque G, Jones K, O'Sullivan C, Giridhar K, Dees EC, Nanda R, Hunter N, Clark A, Wolff A, Krop I, Lin N, Rimawi MF, Yang ES. PMID: 41911748 [PubMed - in process]
	CLO26-083: Potential BMI-Dependent MACE Risk in Postmenopausal Breast Cancer Patients Treated With CDK4/6 Inhibitors: A Mayo Clinic Platform Study. J Natl Compr Canc Netw Sun C, Han Y, Fickel A, Liu L, Lees EH. PMID: 41911730 [PubMed - in process]
	Viewpoint on the Consequences and Mitigation of Cognitive Bias in the Radiological Interpretation of Breast Cancer Imaging Using Artificial Intelligence. JMIR Med Inform Conti L, Capetti B, Battaglia O, Grasso R, Pesapane F, Monzani D, Pravettoni G. PMID: 41911478 [PubMed - indexed for MEDLINE]
	Motor Imagery and Action Observation in Breast Cancer Survivors: Protocol for a Randomized Controlled Trial. JMIR Res Protoc Arnal-Vallés MP, Soto-Ruiz N, Bays-Moneo AB, García-Vivar C, Escalada-Hernández P. PMID: 41911468 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 216158

Seite 1 von 10808

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung